Susquehanna International Group, LLP NABRIVA THERAPEUTICS PLC Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	N/A	-17,548 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	N/A	-69,912 Reduced 79.94%	17,548 $9,000
Q2 2020 Aug 14, 2020	BUY	N/A	50,314 Added 135.45%	87,460 $59,000
Q1 2020 May 15, 2020	SELL	N/A	-128,602 Reduced 77.59%	37,146 $21,000
Q4 2019 Feb 14, 2020	SELL	N/A	-274,421 Reduced 62.34%	165,748 $219,000
Q3 2019 Nov 14, 2019	SELL	N/A	-15,342 Reduced 3.37%	440,169 $880,000
Q2 2019 Aug 16, 2019	BUY	N/A	200 Added 0.04%	455,511 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	N/A	268,844 Added 144.18%	455,311 $1.11 Million
Q1 2019 May 15, 2019	BUY	N/A	160,271 Added 611.81%	186,467 $455,000
Q4 2018 Feb 14, 2019	SELL	N/A	-102,075 Reduced 79.58%	26,196 $38,000
Q3 2018 Nov 14, 2018	BUY	N/A	112,191 Added 697.71%	128,271 $346,000
Q2 2018 Aug 14, 2018	SELL	N/A	-152,289 Reduced 90.45%	16,080 $56,000
Q1 2018 May 15, 2018	BUY	N/A	139,618 Added 485.61%	168,369 $847,000
Q4 2017 Feb 14, 2018	BUY	N/A	28,751	28,751 $172,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.